Venture Capital

With $22M from Palantir insiders, Northslope aims to end one-size-fits-all software with hyper-customized AI built on its famous parent platform.

AI coding assistants are nearly universal, but a new report shows speed gains come with more security flaws, hidden costs, and a developer trust deficit.

A landmark report on 2,000+ companies reveals growth is strong but selective. See why focus, vertical specialization, and core AI now beat hype.

Numa's new AI platform replaces delayed surveys with live customer sentiment, giving dealers the power to solve problems and save sales in the moment.

This Valentine's, ESSENCE's WeLoveUs.shop merges love and legacy, turning gift-giving into a powerful investment in Black women-owned businesses.

As CTV ad complexity soars, publishers are ditching DIY tech for hands-on management. TVIQ's rapid growth reveals a new blueprint for survival.

A US deep-tech firm is setting up in France, using microwave tech to convert waste into sustainable fuels and challenge the petrochemical industry.

With surging revenues and a new body contouring system, Apyx Medical heads to the BTIG conference to prove its growth story is here to stay.

A new report reveals why the most innovative medicines struggle to reach patients, highlighting deep operational gaps in data, tech, and team coordination.

Defense firm Reveal Technology buys Anomaly Six, fusing battlefield AI with controversial global location tracking to create a formidable 'digital arms room'.

Fiera Capital's total assets slipped to $164.1B, as robust private markets growth was overshadowed by significant outflows in its sub-advised business.

Industry leaders at the GenScript Global Forum agree: the era of AI experimentation is over. Now, the hard work of scaling and building trust begins.

Historic mapping firm Sanborn launches a new practice focused on Google Maps, signaling a strategic shift to embed location data into core business operations.

NewcelX sharpens its focus on a Type 1 Diabetes cell therapy, but faces a competitive landscape and significant financial hurdles in its ambitious quest.

A new partnership links instant at-home health screenings to Amazon's One Medical, promising ultimate convenience but raising questions about the future of care.

The FDA has qualified MolecuLightDX's measurement tool, a move set to standardize clinical trials, accelerate innovation, and redefine wound healing.

Philips launches the Evnia 27M2N5500XD, a monitor with a 1000Hz mode. We dive into the tech, the competition, and what it means for esports.

ENA Respiratory's INNA-051 nasal spray, a virus-agnostic shield, has begun Phase II trials, offering new hope for high-risk communities.

Stockholm's Munters Group reports a massive 191% surge in Q4 orders fueled by AI's cooling needs, yet faces a profit squeeze from tariffs and costs.

Amid record layoffs and AI disruption, a new free course aims to help working fathers build a financial safety net. But can it deliver on its promises?